Phase 2 Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You can be male or female, of any race or ethnicity.
- You must be 65 years of age or older and able to sign a consent form yourself.
- You must show no signs of memory or thinking problems based on a standard assessment called the Clinical Dementia Rating (confirm with trial site).
- You must be willing and able to take part in all study activities.
Who may not be able to join:
- You have been told you have, or have symptoms of, restless legs syndrome, narcolepsy, or abnormal sleep behaviors (such as acting out dreams).
- You have a high risk of sleep apnea based on a screening questionnaire, and you do not use a breathing machine (PAP device) at night (confirm with trial site).
- You have untreated sleep apnea with more than 15 breathing interruptions per hour during sleep.
- You have sleep apnea that is not well controlled — either because you don't use your breathing machine enough (less than 4 hours a night on most nights) or still have 10 or more breathing interruptions per hour.
- Your blood test results for a certain protein marker related to brain health fall below a specific level (confirm with trial site).
- You have had a stroke.
- You have a history of kidney problems, specifically if your kidneys are not filtering well enough based on a blood test (confirm with trial site).
- You have a history of liver problems, shown by certain liver enzyme levels being too high on a blood test (confirm with trial site).
- You have HIV/AIDS.
- You have had a problem with drug or alcohol misuse in the past 6 months.
- You regularly drink alcohol 3 or more days a week, where "regularly" means having more than 2 alcoholic drinks within 3 hours of bedtime — though you may still qualify if you agree to reduce your drinking during the study.
- You have a significant medical, behavioral, or mental health condition, or past surgery, that could affect your safety or the study results.
- You have a heart condition requiring medication (except for well-controlled high blood pressure), a lung condition, Type 1 diabetes, a neurological or psychiatric condition requiring medication, untreated depression, or you currently smoke tobacco.
- You take medications that cause drowsiness or that interact with the study drug (lemborexant), unless those medications can be safely stopped.
- Your routine blood test results come back abnormal.
- You currently have thoughts of suicide or self-harm.
- You are not able to speak and understand English.
- You are currently pregnant or breastfeeding.
- The study doctor feels, based on your physical exam, that it would not be appropriate for you to join.
- You have taken part in a clinical trial involving a study drug or device in the 30 days before enrolling in this study.
- You must not join another drug or device study while taking part in this trial.
For an optional part of the study (spinal fluid sample):
- You may not be able to take part in this optional procedure if you take blood thinners, have a bleeding disorder, are allergic to lidocaine or certain skin disinfectants, or have had surgery on your spine or central nervous system (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Brendan Lucey, MD, Washington University School of Medicine
Phone: 314-273-0878
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes plasma pT181/T181 ratio of lemborexant 10 and 20 mg compared to Placebo
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.